Suppr超能文献

妊娠期间无高血压的严重蛋白尿患者体内抗血管生成因子增加:是否需要进行肾活检?

Increased antiangiogenetic factors in severe proteinuria without hypertension in pregnancy: is kidney biopsy necessary?

作者信息

Ohmaru Takako, Ohkuchi Akihide, Muto Shigeaki, Hirashima Chikako, Matsubara Shigeki, Suzuki Mitsuaki

机构信息

Department of Obstetrics and Gynecology, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0498, Japan.

Division of Nephrology, Department of Internal Medicine, Jichi Medical University School of Medicine, Shimotsuke-shi, Tochigi, Japan.

出版信息

CEN Case Rep. 2014 May;3(1):86-89. doi: 10.1007/s13730-013-0092-z. Epub 2013 Aug 23.

Abstract

Acute onset of severe proteinuria during pregnancy obliges physicians to clinically discriminate between gestational proteinuria (GP) and new onset of nephritis. A multiparous woman developed severe proteinuria (5.8 g/day) without hypertension at 32 weeks of gestation. We measured the maternal level of soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sEng), which were extremely high (41.3 and 54.8 ng/ml, respectively), leading us to consider this condition as GP rather than acute onset of nephritis. Thus, we did not perform a kidney biopsy and did not administer a steroid agent. Non-reassuring fetal status required emergency Cesarean section at 33 weeks. Proteinuria decreased to 0.36 g/day at 12 weeks after delivery, and finally disappeared 26 weeks postpartum. Measurement of sFlt-1 and sEng in a pregnant woman with severe proteinuria without hypertension may assist in differential diagnosis of GP from acute onset of nephritis, and thus help to decide whether to perform kidney biopsy during pregnancy.

摘要

妊娠期急性出现的严重蛋白尿迫使医生在临床上区分妊娠蛋白尿(GP)和新发肾炎。一名经产妇在妊娠32周时出现严重蛋白尿(5.8克/天)且无高血压。我们检测了母体可溶性fms样酪氨酸激酶1(sFlt-1)和可溶性内皮糖蛋白(sEng)水平,结果极高(分别为41.3和54.8纳克/毫升),这使我们认为该情况为GP而非肾炎急性发作。因此,我们未进行肾活检,也未给予类固醇药物。胎儿情况不佳需要在33周时紧急剖宫产。产后12周蛋白尿降至0.36克/天,最终在产后26周消失。对无高血压的严重蛋白尿孕妇进行sFlt-1和sEng检测可能有助于鉴别GP与肾炎急性发作,从而有助于决定是否在孕期进行肾活检。

相似文献

1
Increased antiangiogenetic factors in severe proteinuria without hypertension in pregnancy: is kidney biopsy necessary?
CEN Case Rep. 2014 May;3(1):86-89. doi: 10.1007/s13730-013-0092-z. Epub 2013 Aug 23.
2
The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
J Hum Hypertens. 2012 Apr;26(4):236-41. doi: 10.1038/jhh.2011.29. Epub 2011 Mar 31.
4
Lupus nephritis and pregnancy.
Q J Med. 1992 Apr;83(300):315-24.
5
Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
J Clin Endocrinol Metab. 2007 Jul;92(7):2672-9. doi: 10.1210/jc.2006-2349. Epub 2007 Apr 10.
6
Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy.
Am J Obstet Gynecol. 2007 Jul;197(1):28.e1-6. doi: 10.1016/j.ajog.2007.04.010.
7
Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
Hypertens Pregnancy. 2009 Feb;28(1):95-108. doi: 10.1080/10641950802419895.
8
Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Circulation. 2010 Aug 3;122(5):478-87. doi: 10.1161/CIRCULATIONAHA.109.895458. Epub 2010 Jul 19.
10
Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia.
Hypertension. 2011 Nov;58(5):859-66. doi: 10.1161/HYPERTENSIONAHA.111.174417. Epub 2011 Sep 26.

本文引用的文献

1
Postpartum persistent proteinuria after preeclampsia: a single-center experience.
Wien Klin Wochenschr. 2013 Feb;125(3-4):91-5. doi: 10.1007/s00508-013-0320-8. Epub 2013 Jan 19.
2
Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review.
BJOG. 2013 Mar;120(4):412-27. doi: 10.1111/1471-0528.12111. Epub 2013 Jan 15.
3
Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia.
Hypertension. 2011 Nov;58(5):859-66. doi: 10.1161/HYPERTENSIONAHA.111.174417. Epub 2011 Sep 26.
4
Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors.
Hypertens Res. 2011 Feb;34(2):212-7. doi: 10.1038/hr.2010.212. Epub 2010 Nov 4.
6
Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
Hypertens Pregnancy. 2009 Feb;28(1):95-108. doi: 10.1080/10641950802419895.
10
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
N Engl J Med. 2006 Sep 7;355(10):992-1005. doi: 10.1056/NEJMoa055352.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验